Francisco Acín García-rekin lankidetzan egindako argitalpenak (42)

2016

  1. Are the new oral anticoagulants the same as vitamin K antagonists for acute lower limb ischaemia? A systematic review of the evidence

    Angiologia, Vol. 68, Núm. 2, pp. 123-126

  2. Effect of Simvastatin Treatment on “In Vitro” NLRP1 Inflammasome Expression in Peripheral Arterial Disease

    Annals of Vascular Surgery, Vol. 36, pp. 260-264

  3. Effect of bosentan on claudication distance and endothelium-dependent vasodilation in hispanic patients with peripheral arterial disease

    American Journal of Cardiology, Vol. 117, Núm. 2, pp. 295-301

  4. Elevated levels of triglycerides and vldl-cholesterol provoke activation of nlrp1 inflammasome in endothelial cells

    International Journal of Cardiology, Vol. 220, pp. 52-55

  5. Meta-analysis and adjusted indirect comparison of direct oral anticoagulants in prevention of acute limb ischemia in patients with atrial fibrillation

    Current Medical Research and Opinion, Vol. 32, Núm. 6, pp. 1167-1173

  6. Revascularization in Individuals Aged 90 and Older with Critical Lower Limb Ischemia

    Journal of the American Geriatrics Society

2015

  1. Aspirin therapy inhibits NLRP1 (nucleotide-binding domain-like receptor protein 1) inflammasome gene expression in patients with peripheral artery disease

    Journal of Vascular Surgery

  2. Attenuation of early atherosclerotic lesions by immunotolerance with β2 glycoprotein i and the immunomodulatory effectors interleukin 2 and 10 in a murine model

    Journal of Vascular Surgery, Vol. 62, Núm. 6, pp. 1625-1631

  3. C-Reactive protein and endovascular treatment of lower limb peripheral artery disease: An independent prognostic factor

    Journal of Endovascular Therapy, Vol. 22, Núm. 2, pp. 233-239

  4. Circulating anti-β2-glycoprotein i antibodies of peripheral arterial disease patients trigger a genomic overexpression of Toll-like receptor 4 in endothelial cells

    Journal of Vascular Surgery

  5. Protein expression of metalloproteinases-2 (MMP-2) and its tissue inhibitor (TIMP-2) in aorta, fascia and plasma of patients with abdominal aortic aneurysm

    Angiologia, Vol. 67, Núm. 6, pp. 447-453

2014

  1. NLRP1 inflammasome, and not NLRP3, is the key in the shift to proinflammatory state on endothelial cells in peripheral arterial disease

    International Journal of Cardiology, Vol. 172, Núm. 2

  2. Results of infrapopliteal endovascular procedures performed in diabetic patients with critical limb ischemia and tissue loss from the perspective of an angiosome-oriented revascularization strategy

    International Journal of Vascular Medicine, Vol. 2014

  3. Safety and efficacy outcomes of infrapopliteal endovascular procedures performed in patients with critical limb ischemia according to the society for vascular surgery objective performance goals

    Annals of Vascular Surgery, Vol. 28, Núm. 2, pp. 284-294

2013

  1. Analysis of vascular endothelial growth factor gene expression in the tissues of patients with chronic venous insufficiency

    Phlebology, Vol. 28, Núm. 1, pp. 32-37

  2. Circulating anti-beta2-glycoprotein i antibodies are associated with endothelial dysfunction, inflammation, and high nitrite plasma levels in patients with intermittent claudication

    International Journal of Inflammation, Vol. 2013

  3. Inflammatory burden predicts long-term outcomes in endovascular therapy in peripheral arterial disease

    Annals of Vascular Surgery, Vol. 27, Núm. 4, pp. 459-466

  4. The serum of patients with peripheral arterial disease activates the inate immune system through Toll-Like 4 receptors of the endothelial cells

    Angiologia, Vol. 65, Núm. 4, pp. 125-130

2012

  1. Enhanced vascular endothelial growth factor gene expression in ischaemic skin of critical limb ischaemia patients

    International Journal of Vascular Medicine, Vol. 2012

  2. Impact of VEGF polymorphisms on the severity of peripheral artery disease in diabetic patients

    Growth Factors, Vol. 30, Núm. 5, pp. 277-282